Concussions in competitive sports at all levels are the subject of incredible amounts of discussions today. After years of being somewhat dismissed as simply part of a game, the long-term effects of a concussion, not to mention several concussions, are starting to become fully realized with concerted efforts to prevent them now a primary focus of regulators across the board today. All rule changes and other disciplinary actions aside, a key focus is falling where it should; on the health of the victim of the concussion.
Vicor Technologies announced yesterday that it has received Institutional Review Board (IRB) approval from the University of Mississippi Medical Center (UMMC) for a study to assess concussions in competitive athletes using the Company’s revolutionary PD2i Analyzer™. The team at Vicor is making rapid strides and gaining considerable notoriety with the industry recently regarding the PD2i Analyzer as a diagnostic tool to accurately risk stratify specific target populations for future pathological events, including, but not limited to, trauma victims, congestive heart failure patients for cardiac death resulting from arrhythmia or pump failure and diabetics for diabetic autonomic neuropathy (DAN).
David Fater, CEO of Vicor Technologies, stated, “We’re pleased to have approval from UMMC’s IRB permitting us to commence this important study of concussion status in competitive athletes — a first for the PD2i Analyzer™. Being able to effectively assess the extent of a concussion and risk of follow-on pathological events in athletes will enable all involved in assessing the extent of harm incurred during competitive play to better determine player need for advanced care and/or player ability to continue to play unharmed. With this approval, we will begin enrolling patients for this important and exciting clinical research study with an NCAA school, which could lead to other similar studies in the future.”
While this is only the first study to test the PD2i as a diagnostic tool for concussions, it is a huge step in the right direction for identifying potential future risks for those suffering a concussion. Not only is it a critical aspect of sports, but let’s not forget about all the non-athletes in this world who suffer concussions on a daily basis. The high profile NFL and NCAA may be playing an important role in shining light upon an important subject, but the research can benefit all of mankind.
More information about Vicor Technologies can be found on the company’s website at www.vicortech.com
Several videos on the web discussing the NFL and concussions can be viewed at:
NFL Injury Report: Concussions: http://www.youtube.com/watch?v=b6ZFOqyoo1s
Sport Science: NFL Concussions and helmet to hemet collisions: http://www.youtube.com/watch?v=fFkWTGKNLT8
By rough count, Deadspin reported their belief that there have been 46 concussions so far in the NFL this year. They have assembled a compilation of 14 of the hits that caused the concussions: http://deadspin.com/5667912/the-year-in-nfl-concussions-so-far-a-horrifying-video-compilation
About QualityStocks:
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://Gotstocks.QualityStocks.net
Please see disclaimer on QualityStocks website: http://disclaimer.qualitystocks.net
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment